This includes insulin resistance, glucose intolerance, hepatic steatosis, very low adiponectin and leptin levels and hyperphagia, although not the hypertriglyceridemia observed in CGL2 patients. The gene discussed is ADIPOQ; the disease is hypertriglyceridemia.